Literature DB >> 10675481

Regulation of Bcl2 phosphorylation by stress response kinase pathway.

A Basu1, S A You, S Haldar.   

Abstract

The anticancer drugs affecting either microtubule polymerization or depolymerization could trigger Bcl2 phosphorylation in mitotic phase of the cell cycle. By systematic site directed mutagenesis studies, we have previously mapped taxol induced phosphorylation sites to be Ser-70 and 87 residues of Bcl2 protein. Interestingly, sequences surrounding both serine-70 and serine-87 residues represent MAP kinase consensus motif. Since Bcl2 phosphorylation predominantly occurs at site consensus to MAP kinase family members, we were interested to test whether Erk2 or Jun kinase is involved in this pathway. Our in vitro studies document that stress activated kinase, JNK1 is responsible for Bcl2 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675481     DOI: 10.3892/ijo.16.3.497

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1.

Authors:  N Pathan; C Aime-Sempe; S Kitada; S Haldar; J C Reed
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK).

Authors:  Ayesha N Shajahan; Zachary C Dobbin; F Edward Hickman; Sivanesan Dakshanamurthy; Robert Clarke
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

3.  A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.

Authors:  J E Park; J A Lee; S G Park; D H Lee; S J Kim; H-J Kim; C Uchida; T Uchida; B C Park; S Cho
Journal:  Cell Death Differ       Date:  2011-06-10       Impact factor: 15.828

4.  Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.

Authors:  Aruna Basu; Madhusudan Das; Suparna Qanungo; Xue-Jun Fan; Garrett DuBois; Subrata Haldar
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

5.  Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1.

Authors:  N Pathan; C Aime-Sempe; S Kitada; A Basu; S Haldar; J C Reed
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

6.  Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK.

Authors:  Alina Felicia Nica; Chun Chui Tsao; Julie C Watt; Tilahun Jiffar; Svitlana Kurinna; Paul Jurasz; Marina Konopleva; Michael Andreeff; Marek W Radomski; Peter P Ruvolo
Journal:  Cell Cycle       Date:  2008-11-02       Impact factor: 4.534

7.  Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.

Authors:  M Farhat; A Poissonnier; A Hamze; C Ouk-Martin; J-D Brion; M Alami; J Feuillard; C Jayat-Vignoles
Journal:  Cell Death Dis       Date:  2014-05-01       Impact factor: 8.469

8.  Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.

Authors:  Xuerui Yang; Christina Chan
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.